-
1
-
-
84911005810
-
-
Cancer Facts & Figures 2013In Society AC (ed). Atlanta American Cancer Society
-
Cancer Facts & Figures 2013. In Society AC (ed). Atlanta: American Cancer Society 2013.
-
(2013)
-
-
-
2
-
-
8244254377
-
Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: A randomized trial
-
Burris HA 3rd, Moore MJ, Andersen J, et al.: Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: A randomized trial. J Clin Oncol 1997;15:2403-2413.
-
(1997)
J Clin Oncol
, vol.15
, pp. 2403-2413
-
-
Burris, H.A.1
Moore, M.J.2
Andersen, J.3
-
3
-
-
33846405332
-
Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: A randomized controlled trial
-
Oettle H, Post S, Neuhaus P, et al.: Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: A randomized controlled trial. JAMA 2007;297:267-277.
-
(2007)
JAMA
, vol.297
, pp. 267-277
-
-
Oettle, H.1
Post, S.2
Neuhaus, P.3
-
4
-
-
34047216068
-
Review. Molecular background of chemoresistance in pancreatic cancer
-
Zalatnai A, Molnar J: Review. Molecular background of chemoresistance in pancreatic cancer. In Vivo 2007;21:339-347.
-
(2007)
Vivo
, vol.21
, pp. 339-347
-
-
Zalatnai, A.1
Molnar, J.2
-
7
-
-
3042655528
-
Membrane transporters and channels: Role of the transportome in cancer chemosensitivity and chemoresistance
-
Huang Y, Anderle P, Bussey KJ, et al.: Membrane transporters and channels: role of the transportome in cancer chemosensitivity and chemoresistance. Cancer Res 2004;64:4294-4301.
-
(2004)
Cancer Res
, vol.64
, pp. 4294-4301
-
-
Huang, Y.1
Anderle, P.2
Bussey, K.J.3
-
8
-
-
0032905030
-
Control of inducible chemoresistance: Enhanced anti-tumor therapy through increased apoptosis by inhibition of NFκB
-
Wang CY, Cusack JC Jr., Liu R, Baldwin AS Jr.: Control of inducible chemoresistance: Enhanced anti-tumor therapy through increased apoptosis by inhibition of NFκB. Nat Med 1999;5:412-417.
-
(1999)
Nat Med
, vol.5
, pp. 412-417
-
-
Wang, C.Y.1
Cusack, J.C.2
Liu, R.3
Baldwin, A.S.4
-
9
-
-
0036176510
-
Mechanisms of cancer drug resistance
-
Gottesman MM: Mechanisms of cancer drug resistance. Annu Rev Med 2002;53:615-627.
-
(2002)
Annu Rev Med
, vol.53
, pp. 615-627
-
-
Gottesman, M.M.1
-
10
-
-
84872611820
-
Hyaluronan, fluid pressure, and stromal resistance in pancreas cancer
-
Provenzano PP, Hingorani SR: Hyaluronan, fluid pressure, and stromal resistance in pancreas cancer. Br J Cancer 2013;108: 1-8.
-
(2013)
Br J Cancer
, vol.108
, pp. 1-8
-
-
Provenzano, P.P.1
Hingorani, S.R.2
-
11
-
-
78650491562
-
Resistance may not be futile: MicroRNA biomarkers for chemoresistance and potential therapeutics
-
Allen KE, Weiss GJ: Resistance may not be futile: MicroRNA biomarkers for chemoresistance and potential therapeutics. Mol Cancer Ther 2010;9:3126-3136.
-
(2010)
Mol Cancer Ther
, vol.9
, pp. 3126-3136
-
-
Allen, K.E.1
Weiss, G.J.2
-
12
-
-
27544495514
-
A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation
-
Hayashita Y, Osada H, Tatematsu Y, et al.: A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. Cancer Res 2005;65:9628-9632.
-
(2005)
Cancer Res
, vol.65
, pp. 9628-9632
-
-
Hayashita, Y.1
Osada, H.2
Tatematsu, Y.3
-
13
-
-
41749113108
-
MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer
-
Asangani IA, Rasheed SA, Nikolova DA, et al.: MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene 2008;27:2128-2136.
-
(2008)
Oncogene
, vol.27
, pp. 2128-2136
-
-
Asangani, I.A.1
Rasheed, S.A.2
Nikolova, D.A.3
-
14
-
-
35148886434
-
Tumour invasion and metastasis initiated by microRNA-10b in breast cancer
-
Ma L, Teruya-Feldstein J, Weinberg RA: Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature 2007;449:682-688.
-
(2007)
Nature
, vol.449
, pp. 682-688
-
-
Ma, L.1
Teruya-Feldstein, J.2
Weinberg, R.A.3
-
15
-
-
84877698814
-
MicroRNA-182 promotes cell growth, invasion, and chemoresistance by targeting programmed cell death 4 (PDCD4) in human ovarian carcinomas
-
Wang YQ, Guo RD, Guo RM, et al.: MicroRNA-182 promotes cell growth, invasion, and chemoresistance by targeting programmed cell death 4 (PDCD4) in human ovarian carcinomas. J Cell Biochem 2013;114:1464-1473.
-
(2013)
J Cell Biochem
, vol.114
, pp. 1464-1473
-
-
Wang, Y.Q.1
Guo, R.D.2
Guo, R.M.3
-
16
-
-
84879177004
-
MicroRNA-30c inhibits human breast tumour chemotherapy resistance by regulating TWF1 and IL-11
-
Bockhorn J, Dalton R, Nwachukwu C, et al.: MicroRNA-30c inhibits human breast tumour chemotherapy resistance by regulating TWF1 and IL-11. Nat Commun 2013;4:1393.
-
(2013)
Nat Commun
, vol.4
, pp. 1393
-
-
Bockhorn, J.1
Dalton, R.2
Nwachukwu, C.3
-
17
-
-
84878986540
-
A microRNA signature defines chemoresistance in ovarian cancer through modulation of angiogenesis
-
Vecchione A, Belletti B, Lovat F, et al.: A microRNA signature defines chemoresistance in ovarian cancer through modulation of angiogenesis. Proc Natl Acad Sci U S A 2013;110:9845-9850.
-
(2013)
Proc Natl Acad Sci U S A
, vol.110
, pp. 9845-9850
-
-
Vecchione, A.1
Belletti, B.2
Lovat, F.3
-
18
-
-
84872496432
-
MicroRNAs as potential biomarkers in human solid tumors
-
Shen J, Stass SA, Jiang F: MicroRNAs as potential biomarkers in human solid tumors. Cancer Lett 2013;329:125-136.
-
(2013)
Cancer Lett
, vol.329
, pp. 125-136
-
-
Shen, J.1
Stass, S.A.2
Jiang, F.3
-
19
-
-
66449136951
-
Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model
-
Kota J, Chivukula RR, O'Donnell KA, et al.: Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model. Cell 2009;137:1005-1017.
-
(2009)
Cell
, vol.137
, pp. 1005-1017
-
-
Kota, J.1
Chivukula, R.R.2
O'Donnell, K.A.3
-
20
-
-
84878858306
-
Therapeutic delivery of microRNA-29b by cationic lipoplexes for lung cancer
-
Wu Y, Crawford M, Mao Y, et al.: Therapeutic delivery of microRNA-29b by cationic lipoplexes for lung cancer. Mol Ther Nucleic Acids 2013;2:e84.
-
(2013)
Mol Ther Nucleic Acids
, vol.2
, pp. e84
-
-
Wu, Y.1
Crawford, M.2
Mao, Y.3
-
21
-
-
77950560584
-
MicroRNA-21 is induced early in pancreatic ductal adenocarcinoma precursor lesions
-
du Rieu MC, Torrisani J, Selves J, et al.: MicroRNA-21 is induced early in pancreatic ductal adenocarcinoma precursor lesions. Clin Chem 2010;56:603-612.
-
(2010)
Clin Chem
, vol.56
, pp. 603-612
-
-
Du Rieu, M.C.1
Torrisani, J.2
Selves, J.3
-
22
-
-
57049090610
-
MicroRNA-21 is overexpressed in pancreatic cancer and a potential predictor of survival
-
Dillhoff M, Liu J, Frankel W, et al.: MicroRNA-21 is overexpressed in pancreatic cancer and a potential predictor of survival. J Gastrointest Surg 2008;12:2171-2176.
-
(2008)
J Gastrointest Surg
, vol.12
, pp. 2171-2176
-
-
Dillhoff, M.1
Liu, J.2
Frankel, W.3
-
23
-
-
84882749158
-
MicroRNA-21 in pancreatic ductal adenocarcinoma tumor-associated fibroblasts promotes metastasis
-
Kadera BE, Li L, Toste PA, et al.: MicroRNA-21 in pancreatic ductal adenocarcinoma tumor-associated fibroblasts promotes metastasis. PLoS One 2013;8:e71978.
-
(2013)
PLoS One
, vol.8
, pp. e71978
-
-
Kadera, B.E.1
Li, L.2
Toste, P.A.3
-
24
-
-
77956296766
-
Identification of microRNA-21 as a biomarker for chemoresistance and clinical outcome following adjuvant therapy in resectable pancreatic cancer
-
Hwang JH, Voortman J, Giovannetti E, et al.: Identification of microRNA-21 as a biomarker for chemoresistance and clinical outcome following adjuvant therapy in resectable pancreatic cancer. PLoS One 2010;5:e10630.
-
(2010)
PLoS One
, vol.5
, pp. e10630
-
-
Hwang, J.H.1
Voortman, J.2
Giovannetti, E.3
-
25
-
-
77953169001
-
MicroRNA-21 in pancreatic cancer: Correlation with clinical outcome and pharmacologic aspects underlying its role in the modulation of gemcitabine activity
-
Giovannetti E, Funel N, Peters GJ, et al.: MicroRNA-21 in pancreatic cancer: Correlation with clinical outcome and pharmacologic aspects underlying its role in the modulation of gemcitabine activity. Cancer Res 2010;70:4528-4538.
-
(2010)
Cancer Res
, vol.70
, pp. 4528-4538
-
-
Giovannetti, E.1
Funel, N.2
Peters, G.J.3
-
26
-
-
78650500590
-
MicroRNA-21 induces resistance to 5-fluorouracil by down-regulating human DNA MutS homolog 2 (hMSH2
-
Valeri N, Gasparini P, Braconi C, et al.: MicroRNA-21 induces resistance to 5-fluorouracil by down-regulating human DNA MutS homolog 2 (hMSH2). Proc Natl Acad Sci U S A 2010;107: 21098-21103.
-
(2010)
Proc Natl Acad Sci U S A
, vol.107
, pp. 21098-21103
-
-
Valeri, N.1
Gasparini, P.2
Braconi, C.3
-
27
-
-
78149469070
-
MicroRNA-21 induces resistance to the anti-tumour effect of interferon-alpha/5-fluorouracil in hepatocellular carcinoma cells
-
Tomimaru Y, Eguchi H, Nagano H, et al.: MicroRNA-21 induces resistance to the anti-tumour effect of interferon-alpha/5-fluorouracil in hepatocellular carcinoma cells. Br J Cancer 2010;103:1617-1626.
-
(2010)
Br J Cancer
, vol.103
, pp. 1617-1626
-
-
Tomimaru, Y.1
Eguchi, H.2
Nagano, H.3
-
28
-
-
79955841030
-
Fluorouracil-based chemoradiation with either gemcitabine or fluorouracil chemotherapy after resection of pancreatic adenocarcinoma: 5'year analysis of the U.S. Intergroup/RTOG 9704 phase III trial
-
Regine WF, Winter KA, Abrams R, et al.: Fluorouracil-based chemoradiation with either gemcitabine or fluorouracil chemotherapy after resection of pancreatic adenocarcinoma: 5-year analysis of the U.S. Intergroup/RTOG 9704 phase III trial. Ann Surg Oncol 2011;18:1319-1326.
-
(2011)
Ann Surg Oncol
, vol.18
, pp. 1319-1326
-
-
Regine, W.F.1
Winter, K.A.2
Abrams, R.3
-
29
-
-
84871157346
-
Hyaluronan impairs vascular function and drug delivery in a mouse model of pancreatic cancer
-
Jacobetz MA, Chan DS, Neesse A, et al.: Hyaluronan impairs vascular function and drug delivery in a mouse model of pancreatic cancer. Gut 2013;62:112-120.
-
(2013)
Gut
, vol.62
, pp. 112-120
-
-
Jacobetz, M.A.1
Chan, D.S.2
Neesse, A.3
-
30
-
-
38049115129
-
Endogenous human microRNAs that suppress breast cancer metastasis
-
Tavazoie SF, Alarcon C, Oskarsson T, et al.: Endogenous human microRNAs that suppress breast cancer metastasis. Nature 2008;451:147-152.
-
(2008)
Nature
, vol.451
, pp. 147-152
-
-
Tavazoie, S.F.1
Alarcon, C.2
Oskarsson, T.3
-
31
-
-
84883818845
-
Expression, tissue distribution and function of miR-21 in esophageal squamous cell carcinoma
-
Nouraee N, Van Roosbroeck K, Vasei M, et al.: Expression, tissue distribution and function of miR'21 in esophageal squamous cell carcinoma. PLoS One 2013;8:e73009.
-
(2013)
PLoS One
, vol.8
, pp. e73009
-
-
Nouraee, N.1
Van Roosbroeck, K.2
Vasei, M.3
-
32
-
-
55549120234
-
MicroRNA miR'21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis
-
Yan LX, Huang XF, Shao Q, et al.: MicroRNA miR'21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis. RNA 2008;14:2348-2360.
-
(2008)
RNA
, vol.14
, pp. 2348-2360
-
-
Yan, L.X.1
Huang, X.F.2
Shao, Q.3
-
33
-
-
38749089854
-
MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma
-
Schetter AJ, Leung SY, Sohn JJ, et al.: MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. JAMA 2008;299:425-436.
-
(2008)
JAMA
, vol.299
, pp. 425-436
-
-
Schetter, A.J.1
Leung, S.Y.2
Sohn, J.J.3
-
34
-
-
34547524771
-
MicroRNA'21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer
-
Meng F, Henson R, Wehbe-Janek H, et al.: MicroRNA'21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 2007;133:647-658.
-
(2007)
Gastroenterology
, vol.133
, pp. 647-658
-
-
Meng, F.1
Henson, R.2
Wehbe-Janek, H.3
-
35
-
-
66849124564
-
MicroRNA'21 modulates biological functions of pancreatic cancer cells including their proliferation, invasion, and chemoresistance
-
Moriyama T, Ohuchida K, Mizumoto K, et al.: MicroRNA'21 modulates biological functions of pancreatic cancer cells including their proliferation, invasion, and chemoresistance. Mol Cancer Ther 2009;8:1067-1074.
-
(2009)
Mol Cancer Ther
, vol.8
, pp. 1067-1074
-
-
Moriyama, T.1
Ohuchida, K.2
Mizumoto, K.3
-
36
-
-
40449113435
-
Fluorouracil vs. Gemcitabine chemotherapy before and after fluorouracilbased chemoradiation following resection of pancreatic adenocarcinoma: A randomized controlled trial
-
Regine WF, Winter KA, Abrams RA, et al.: Fluorouracil vs. gemcitabine chemotherapy before and after fluorouracilbased chemoradiation following resection of pancreatic adenocarcinoma: a randomized controlled trial. JAMA 2008;299: 1019-1026.
-
(2008)
JAMA
, vol.299
, pp. 1019-1026
-
-
Regine, W.F.1
Winter, K.A.2
Abrams, R.A.3
-
37
-
-
84875226059
-
Pancreatic ductal adenocarcinoma: Is there a survival difference for R1 resections versus locally advanced unresectable tumors- What is a true"R0 resection?
-
Konstantinidis IT, Warshaw AL, Allen JN, et al.: Pancreatic ductal adenocarcinoma: is there a survival difference for R1 resections versus locally advanced unresectable tumors- What is a "true" R0 resection- Ann Surg 2013;257:731-736.
-
(2013)
Ann Surg
, vol.257
, pp. 731-736
-
-
Konstantinidis, I.T.1
Warshaw, A.L.2
Allen, J.N.3
-
38
-
-
84866863598
-
The prognostic importance of miR'21 in stage II colon cancer: A population-based study
-
Kjaer-Frifeldt S, Hansen TF, Nielsen BS, et al.: The prognostic importance of miR'21 in stage II colon cancer: A population-based study. Br J Cancer 2012;107:1169-1174.
-
(2012)
Br J Cancer
, vol.107
, pp. 1169-1174
-
-
Kjaer-Frifeldt, S.1
Hansen, T.F.2
Nielsen, B.S.3
-
39
-
-
79951671912
-
High levels of MicroRNA'21 in the stroma of colorectal cancers predict short disease-free survival in stage II colon cancer patients
-
Nielsen BS, Jorgensen S, Fog JU, et al.: High levels of MicroRNA'21 in the stroma of colorectal cancers predict short disease-free survival in stage II colon cancer patients. Clin Exp Metastasis 2011;28:27-38.
-
(2011)
Clin Exp Metastasis
, vol.28
, pp. 27-38
-
-
Nielsen, B.S.1
Jorgensen, S.2
Fog, J.U.3
-
40
-
-
84876786403
-
Astarring role for stellate cells in the pancreatic cancer microenvironment
-
Apte MV, Wilson JS, Lugea A, Pandol SJ:Astarring role for stellate cells in the pancreatic cancer microenvironment. Gastroenterology 2013;144:1210-1219.
-
(2013)
Gastroenterology
, vol.144
, pp. 1210-1219
-
-
Apte, M.V.1
Wilson, J.S.2
Lugea, A.3
Pandol, S.J.4
|